Magnetic resonance imaging in breast cancer

European Journal of Surgical Oncology

Volumn 32, Issue 9, 2006, Pages 901-910

  Van Goethem, M ^a   Tjalma, W ^a   Schelfout, K ^a   Verslegers, I ^a   Biltjes, I ^a   Parizel, P ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Breast cancer; Magnetic resonance mammography

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SIZE; CANCER STAGING; CARCINOMA IN SITU; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; HUMAN; INVASIVE CARCINOMA; MAMMOGRAPHY; METASTASIS; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 33750410568     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.06.009     Document Type: Review

References (88)

1. Harms S., Lehman C., Klimberg S., and Garcia R. Reports of the introductional working groups on breast MRI. Breast J 10 (2004) S1-S19
2. English J. Importance of breast awareness in identification of breast cancer. Nurs Times 99 (2003) 18-19
3. Catalano R., Winett L., Wallack L., and Satariano W. Evaluating a campaign to detect early stage breast tumors in the United States. Eur J Epidemiol 18 (2003) 545-550
4. Zonderland H. The role of ultrasound in the diagnosis of breast cancer. Semin Ultrasound CT MR 21 (2000) 317-324
5. Santiago R.J., Wu L., Harris E., et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 58 (2004) 233-240
6. Benda R.K., Mendenhall N.P., Lind D.S., et al. Breast-conserving therapy (BCT) for early-stage breast cancer. J Surg Oncol 85 (2004) 14-27
7. Winchester D.P., and Cox J.D. Standards for diagnosis and management of invasive breast carcinoma. American college of radiology. American college of surgeons. College of American pathologists. Society of Surgical Oncology. CA Cancer J Clin 48 (1998) 83-107
8. Holland R., Connolly J.L., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8 (1990) 113-118
9. Ghossein N.A., Alpert S., Barba J., et al. Breast cancer. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively. Arch Surg 127 (1992) 411-415
10. Meric F., Mirza N.Q., Vlastos G., et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97 (2003) 926-933
11. Goldstein N.S., Kestin L., and Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol 120 (2003) 500-527
12. Silverstein M.J. Ductal carcinoma in situ of the breast: a surgeon's disease. Ann Surg Oncol 6 (1999) 802-810
13. Fredriksson I., Liljegren G., Palm-Sjovall M., et al. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 90 (2003) 1093-1102
14. Boland G.P., Chan K.C., Knox W.F., Roberts S.A., and Bundred N.J. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg 90 (2003) 426-432
15. Solin L.J., Fourquet A., Vicini F.A., et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 50 (2001) 991-1002
16. Vicini F.A., Kestin L., Huang R., and Martinez A. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?. Cancer 97 (2003) 910-919
17. Barros A.C., Teixeira L.C., Nisida A.C., Pinotti M., and Pinotti J.A. Prognostic effects of local recurrence after conservative treatment for early infiltrating breast carcinoma. Tumori 88 (2002) 376-378
18. Mandelson M.T., Oestreicher N., Porter P.L., et al. Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst 92 (2000) 1081-1087
19. Heywang-Kobrunner S. Brustkrebsdiagnostik mit MR/überblick nach 1250 patienten. Electromedica 61 (1993) 43-52
20. Harms S., Flamig D., Hesley K., et al. MR Imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187 (1993) 493-501
21. Gilles R., Zafrani B., Guinebretière J.M., et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 196 (1995) 415-419
22. Boetes C., Mus R., and Holland R. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197 (1995) 743-747
23. Gilles R., Meunier M., Lucidarme O., et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 20 (1996) 9-14
24. Soderstrom C., Harms S., Copit D., et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 201 (1996) 427-432
25. Fischer U., Westerhof J., Brinck, Koabiowska M., Schauer A., and Grabbe E. Das duktale in-situ-karzinom in der dynamischen MR-mammographie bei 1,5T. Fortschr Röntgenstr 164 (1996) 290-294
26. Boné B., Aspelin P., Bronge L., Isberg B., Perbeck L., and Veress I. Sensitivity and specificity of MR mammography with histopathologic correlation in 250 breasts. Acta Radiol 37 (1996) 208-213
27. Sittek H., Kessler M., Heuck A.F., et al. Morphologie und Anreichungsverhalten des duktalen In-situ-Karzinoms in der dynamischen MR-Mammographie bei 1,0 T [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography]. Rofo Fortschr Rontgenstr 167 (1997) 247-251
28. Boetes C., Strijk S., Holland R., Barentsz J., Van Der Sluis, and Ruijs J. False-negative MR imaging of malignant breast tumors. Eur Radiol 7 (1997) 1231-1234
29. Orel S., Mendonca M.H., Reynolds C., Schnall M., Solin L., and Sullivan D. MR imaging of ductal carcinoma in situ. Radiology 202 (1997) 413-420
30. Mumtaz H., Hall-Craggs M., Davidson T., et al. Staging of symptomatic primary breast cancer with MR imaging. AJR 169 (1997) 417-424
31. Fischer U., Kopka L., and Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213 (1999) 881-888
32. Westerhof J.P., Fischer U., Moritz J.D., and Oestmann J.W. MR imaging of mammographically detected clustered microcalcifications: is there any value?. Radiology 207 (1998) 675-681
33. Viehweg P., Lampe D., Buchmann J., and Heywang-Kobrunner S.H. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 11 (2000) 129-137
34. Van Goethem M., Schelfout K., Kersschot E., et al. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. JBR-BTR 88 (2005) 225-232
35. Cross M.J., Harms S.E., Cheek J.H., Peters G.N., and Jones R.C. New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging. Am J Surg 166 (1993) 749-753 discussion 753-5
36. Kriege M., Brekelmans C.T., Boetes C., et al. Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
37. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 (2004) 1317-1325
38. Frouge C., Guinebretiere J.M., Contesso G., Di Paola R., and Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 29 (1994) 1043-1049
39. Nagy J.A., Brown L.F., Senger D.R., et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948 (1989) 305-326
40. Kuhl C. MRI of the breast. Adv MRI Contrast 5 (1998) 56-69
41. Kuhl C.K., Bieling H.B., Gieseke J., et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203 (1997) 137-144
42. Nunes L.W., Schnall M.D., Orel S.G., et al. Breast MR imaging: interpretation model. Radiology 202 (1997) 833-841
43. Berg W.A., Gutierrez L., Nessaiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
44. Mendelson E., Harris K., Doshu N., and Tobon H. Infiltrating lobular carcinoma: mammographic patterns with pathologic correlation. AJR 153 (1989) 265-271
45. Gilles R., Guinebretiere J.M., Lucidarme O., et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191 (1994) 625-631
46. Schelfout K., Van Goethem M., Kersschot E., et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol 14 (2004) 1209-1216
47. Qayyum A., Birdwell R.L., Daniel B.L., et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR 178 (2002) 1227-1232
48. Weinstein S.P., Orel S.G., Heller R., et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR 176 (2001) 399-406
49. Boetes C., Veltman J., van Die L., Bult P., Wobbes T., and Barentsz J.O. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86 (2004) 31-37
50. European Organization for Research and Treatment of Cancer (EORTC) breast cancer cooperative group, and EORTC breast cancer cooperative group. EORTC manual for clinical research and treatment in breast cancer. 4th ed. (2000), Excerpta Medica, Almere, the Netherlands
51. Stomper P.C., and Connolly J.L. Mammographic features predicting an extensive intraductal component in early-stage infiltrating ductal carcinoma. AJR 158 (1992) 269-272
52. Tilakaratna A.D., Rodrigo T., and de Silva M.V. Extensive intraduct component in invasive duct carcinoma of the breast: prevalence and significance in a south Asian setting. Indian J Cancer 37 (2000) 1-3
53. Boyages J., Recht A., Connolly J.L., et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 19 (1990) 29-41
54. Schnitt S.J., Abner A., Gelman R., et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74 (1994) 1746-1751
55. Gage I., Schnitt S.J., Nixon A.J., et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78 (1996) 1921-1928
56. Holland R., and Hendriks J. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 3 (1994) 181-192
57. Satake H., Shimamoto K., Sawaki A., et al. Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. Eur Radiol 10 (2000) 1726-1732
58. Kerslake R.W., Carleton P.J., Fox J.N., et al. Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast. Clin Radiol 50 (1995) 440-454
59. Hata T., Takahashi H., Watanabe K., et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg 198 (2004) 190-197
60. Van Goethem M., Schelfout K., Kersschot E., et al. Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination. Eur Radiol 14 (2004) 1363-1370
61. Nakahara H., Namba K., Fukami A., et al. Three-dimensional MR imaging of mammographically detected suspicious microcalcifications. Breast Cancer 8 (2001) 116-124
62. Fornage B., Toubas O., and Morel M. Clinical, mammographic and sonographic determination of preoperative breast cancer size. Cancer 56 (1985) 979-990
63. Van Goethem M., Schelfout K., Dijckmans L., et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 14 (2004) 809-816
64. Davis P.L., Staiger M.J., Harris K.B., et al. Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat 37 (1996) 1-9
65. Rodenko G., Harms S., Pruneda J., et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR 167 (1996) 1415-1419
66. Kneeshaw P.J., Turnbull L.W., Smith A., and Drew P.J. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol 29 (2003) 32-37
67. Schelfout K., Van Goethem M., Kersschot E., et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 30 (2004) 501-507
68. Tillman G., Orel S., Schnall M., Schultz D., Tan J., and Solin L. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 20 (2002) 3413-3423
69. Date S. Diagnosis of intraductal spread of breast cancer by high-resolution MR imaging: correlation between MR imaging and pathohistological findings. Nippon Igaku Hoshagen Gakkai Zasshi 58 (1998) 212-220
70. Holland R., Hendriks J., Verbeek A., Mravunac M., and Schuurmans Stekhoven J. Extent, distribution and mammographic/histopathologic correlations of breast ductal carcinoma in situ. Lancet 335 (1990) 519-522
71. Frei K.A., Bonel H.M., Pelte M.F., Hylton N.M., and Kinkel K. Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol 40 (2005) 363-367
72. Egan R.L. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 49 (1982) 1123-1130
73. Orel S., Schnall M., Powell C., et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196 (1995) 16-18
74. Rieber A., Merkle E., Bohm W., Brambs H.J., and Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or controlateral secondary carcinoma. J Comput Assist Tomogr 21 (1997) 773-779
75. Gatzemeier W., Liersch T., Stylianou A., Buttler A., Becker H., and Fischer U. Präoperative MR mammographie beim mammacarcinom. Chirurg 70 (1999) 1460-1468
76. Liberman L., Morris E.A., Dershaw D.D., Abramson A.F., and Tan L.K. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR 180 (2003) 901-910
77. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Italian Trial for Breast MR in Multifocal/Multicentric Cancer Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR 183 (2004) 1149-1157
78. Lee S.G., Orel S.G., Woo I.J., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226 (2003) 773-778
79. Orel S.G., and Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220 (2001) 13-30
80. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR 180 (2003) 333-341
81. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98 (2003) 468-473
82. Gump F.E., Shikora S., Habif D.V., Kister S., Logerfo P., and Estabrook A. The extent and distribution of cancer in breasts with palpable primary tumors. Ann Surg 204 (1986) 384-390
83. Faverly D.R., Burgers L., Bult P., and Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11 (1994) 193-198
84. Technology Evaluation Center (TEC). Breast MRI for detection or diagnosis of primary or recurrent breast cancer. Assessment Program vol. 19 No. 1 (2004)
85. Douek M., Davidson T., Hall-Craggs, Lakhani S., Baum M., and Taylor I. Does preoperative MRI influence the extent of surgical resection in conservative breast cancer surgery?. Breast 8 (1999) 84-88
86. Fischer U., Zachariae O., Baum F., von Heyden D., Funke M., and Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14 (2004) 1725-1731
87. Perlet C., Heywang-Kobrunner S.H., Heinig A., et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer 106 (2006) 982-990
88. Anastassiades O., Iakovou E., Stavridou N., and Gogas J. Karameris Multicentricity in breast cancer. A study of 366 cases. Am J Clin Pathol 99 (1993) 238-243